There is limited data available from randomized trials comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgery in patients with different risks and follow-up periods of at least four years or longer.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic Valve
October 24, 2024
October 17, 2024
The AVATAR Trial addressed the question of when and how to treat asymptomatic patients with severe aortic stenosis (AS) and normal left ventricular (LV) systolic function. In the current report, the authors present the extended follow-up.
October 10, 2024
The aim of this study was to compare the clinical outcomes between surgical cut-down (SC) and the percutaneous (PC) approach. In the matched population, 15 out of 323 patients (4.6 percent) in the SC group versus 34 out of 323 patients in the PC group (11 percent) experienced minor vascular complications (p = 0.02).
September 5, 2024
The authors aimed to analyze the impact of preoperative septic cerebral embolism on early and late postoperative outcomes in patients with infective endocarditis (IE) undergoing valve surgery.
August 22, 2024
The utility of operating room extubation (ORE) after cardiac surgery over fast-track extubation (FTE) within 6 hours remains contested. The authors hypothesized ORE would be associated with equivalent rates of morbidity and mortality, relative to FTE. They found that ORE was associated with similar or improved outcomes compared to FTE.
Deep Dive Into Aortic Surgery: Mini-Access David Procedure—Endoscopic Assessment of Valve Competency
July 19, 2024
]]>
July 18, 2024
The selection of valve prostheses for patients undergoing surgical aortic valve replacement (SAVR) remains controversial. In this study, the authors compared the long-term outcomes of patients undergoing aortic valve replacement with biological or mechanical aortic valve prostheses.
June 18, 2024
This video presents the case of a thirty-year-old woman who underwent a commando procedure to treat bacterial endocarditis.
June 13, 2024
This paper reports the interim findings from the clinical registry that was initiated after FDA approval to validate the findings of the 386 PROACT trial for the On-X aortic valve. The original trial showed that low dose warfarin (INR range 1.5-2.0) and aspirin were safe starting at least three months after On-X aortic valve implantation.
June 13, 2024
This video describes the authors’ technique for harvesting valved aortic and pulmonary homografts that are needed for various surgical cardiac reconstructions. from human cadaveric hearts.